Liver Dysfunction clinical trials at UCSF
1 research study open to new patients
open to eligible people ages 18 years and up
INTERLIVER is a prospective observational study of the relationship of the molecular phenotype of 300 liver transplant biopsies to the histologic phenotype and the clinical features and outcomes. A segment of a biopsy performed as standard-of-care for indications, or by center protocol, will be used for gene expression study.
San Francisco, California and other locations